{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:47:50Z","timestamp":1791899270342,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5T32CA154274-13"],"award-info":[{"award-number":["5T32CA154274-13"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5T32GM008181-33,34"],"award-info":[{"award-number":["5T32GM008181-33,34"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA154624"],"award-info":[{"award-number":["R01-CA154624"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02346-0","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:25:55Z","timestamp":1784280355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Melanoma cell adhesion molecule (MCAM) mediates microtentacle generation, homotypic clustering, and reattachment of non-adherent breast tumor cells"],"prefix":"10.1186","volume":"28","author":[{"given":"David A.","family":"Annis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyata N.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makenzy","family":"Mull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin E.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Destiny O.","family":"Omili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele I.","family":"Vitolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1120\/jacmp.v9i4.2781","volume":"9","author":"G Li","year":"2008","unstructured":"Li G, et al. Accuracy of 3D volumetric image registration based on CT, MR and PET\/CT phantom experiments. J Appl Clin Med Phys. 2008;9:17\u201336.","journal-title":"J Appl Clin Med Phys"},{"key":"2346_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-med-062310-094219","volume":"63","author":"C Alix-Panabi\u00e8res","year":"2012","unstructured":"Alix-Panabi\u00e8res C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012;63:199\u2013215.","journal-title":"Annu Rev Med"},{"key":"2346_CR3","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillek\u00e5s","year":"2019","unstructured":"Dillek\u00e5s H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8:5574\u20136.","journal-title":"Cancer Med"},{"key":"2346_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2346_CR5","first-page":"1","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:1\u201317.","journal-title":"Signal Transduct Target Ther"},{"key":"2346_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110\u201322.","journal-title":"Cell"},{"key":"2346_CR7","doi-asserted-by":"crossref","unstructured":"Nasr, M. M. & Lynch, C. C. How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy. Cancer Metastasis Rev. (2023)","DOI":"10.1007\/s10555-023-10124-z"},{"key":"2346_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188770","volume":"1877","author":"K Morris","year":"2022","unstructured":"Morris K, Schnoor B, Papa A-L. Platelet cancer cell interplay as a new therapeutic target. Biochimica et Biophysica Acta (BBA) - Reviews Cancer. 2022;1877:188770.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews Cancer"},{"key":"2346_CR9","first-page":"1","volume":"55","author":"L Zhang","year":"2026","unstructured":"Zhang L, Yuan Y, Deng Y, Wang L, Chen F. Platelet-circulating tumor cell crosstalk: a pivotal target in cancer diagnosis and therapy (review). Oncol Rep. 2026;55:1\u201314.","journal-title":"Oncol Rep"},{"key":"2346_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103502","volume":"167","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang Y, Ding Y, Zhuang R. Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules. Crit Rev Oncol Hematol. 2021;167:103502.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2346_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba BM, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019;566:553\u20137.","journal-title":"Nature"},{"key":"2346_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI193521","volume":"135","author":"D Scholten","year":"2025","unstructured":"Scholten D, et al. Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis. J Clin Invest. 2025;135:e193521.","journal-title":"J Clin Invest"},{"key":"2346_CR13","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1158\/0008-5472.CAN-10-1569","volume":"70","author":"MA Matrone","year":"2010","unstructured":"Matrone MA, Whipple RA, Balzer EM, Martin SS. Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells. Cancer Res. 2010;70:7737\u201341.","journal-title":"Cancer Res"},{"key":"2346_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","volume":"176","author":"S Gkountela","year":"2019","unstructured":"Gkountela S, et al. Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell. 2019;176:98-112.e14.","journal-title":"Cell"},{"key":"2346_CR15","first-page":"1","volume":"5","author":"Z Wang","year":"2020","unstructured":"Wang Z, et al. CD146, from a melanoma cell adhesion molecule to a signaling receptor. Signal Transduct Target Ther. 2020;5:1\u201315.","journal-title":"Signal Transduct Target Ther"},{"key":"2346_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1073\/pnas.1111053108","volume":"109","author":"Q Zeng","year":"2012","unstructured":"Zeng Q, et al. CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A. 2012;109:1127\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2346_CR17","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s13277-012-0417-0","volume":"33","author":"Z Wu","year":"2012","unstructured":"Wu Z, et al. MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells. Tumour Biol. 2012;33:1619\u201328.","journal-title":"Tumour Biol"},{"key":"2346_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00109-025-02617-x","volume":"104","author":"B Mierzejewski","year":"2025","unstructured":"Mierzejewski B, Kulma D, Brzoska E. The multifaceted roles of MCAM in development, homeostasis, pathological conditions, and cancer. J Mol Med. 2025;104:1.","journal-title":"J Mol Med"},{"key":"2346_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2012.11.049","volume":"330","author":"Z Wang","year":"2013","unstructured":"Wang Z, Yan X. CD146, a multi-functional molecule beyond adhesion. Cancer Lett. 2013;330:150\u201362.","journal-title":"Cancer Lett"},{"key":"2346_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/biomedicines8120633","volume":"8","author":"A Joshkon","year":"2020","unstructured":"Joshkon A, et al. Role of CD146 (MCAM) in physiological and pathological angiogenesis\u2014contribution of new antibodies for therapy. Biomedicines. 2020;8:633.","journal-title":"Biomedicines"},{"key":"2346_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043752","author":"A-M Imbert","year":"2012","unstructured":"Imbert A-M, et al. CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in epithelial to mesenchymal transition. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0043752.","journal-title":"PLoS ONE"},{"key":"2346_CR22","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/bcr2215","volume":"11","author":"G Zabouo","year":"2009","unstructured":"Zabouo G, et al. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res BCR. 2009;11:R1.","journal-title":"Breast Cancer Res BCR"},{"key":"2346_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-113","volume":"11","author":"G Zeng","year":"2011","unstructured":"Zeng G, Cai S, Wu G-J. Up-regulation of METCAM\/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells. BMC Cancer. 2011;11:113.","journal-title":"BMC Cancer"},{"key":"2346_CR24","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2904140","volume":"29","author":"N Wei","year":"2024","unstructured":"Wei N, et al. CD146 promotes EMT-mediated migration and invasion of NSCLC via PI3K\/Akt signaling pathway. Front Biosci-Landmark. 2024;29:140.","journal-title":"Front Biosci-Landmark"},{"key":"2346_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2018.05.016","volume":"430","author":"Y Ma","year":"2018","unstructured":"Ma Y, et al. CD146 mediates an E-cadherin-to-N-cadherin switch during TGF-\u03b2 signaling-induced epithelial-mesenchymal transition. Cancer Lett. 2018;430:201\u201314.","journal-title":"Cancer Lett"},{"key":"2346_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.prp.2011.09.009","volume":"207","author":"W Li","year":"2011","unstructured":"Li W, et al. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: comparative study with invasive ductal carcinoma-not otherwise specified. Pathol Res Pract. 2011;207:739\u201346.","journal-title":"Pathol Res Pract"},{"key":"2346_CR27","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/cac2.12495","volume":"43","author":"J Chen","year":"2023","unstructured":"Chen J, et al. CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway. Cancer Commun. 2023;43:1244\u201366.","journal-title":"Cancer Commun"},{"key":"2346_CR28","first-page":"619","volume":"66","author":"P Dudzik","year":"2019","unstructured":"Dudzik P, et al. Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression. Acta Biochim Pol. 2019;66:619\u201325.","journal-title":"Acta Biochim Pol"},{"key":"2346_CR29","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1182\/blood.V98.13.3677","volume":"98","author":"N Bardin","year":"2001","unstructured":"Bardin N, et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood. 2001;98:3677\u201384.","journal-title":"Blood"},{"key":"2346_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06874-9","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang S, et al. MCAM interacts with integrin \u03b21 to promote EGFR-TKI resistance in lung adenocarcinoma through the JAK3 signalling pathway. J Transl Med. 2025;23:831.","journal-title":"J Transl Med"},{"key":"2346_CR31","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.yexcr.2007.02.001","volume":"313","author":"RA Whipple","year":"2007","unstructured":"Whipple RA, Cheung AM, Martin SS. Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment. Exp Cell Res. 2007;313:1326\u201336.","journal-title":"Exp Cell Res"},{"key":"2346_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13058-022-01506-2","volume":"24","author":"KN Thompson","year":"2022","unstructured":"Thompson KN, et al. Microtubule disruption reduces metastasis more effectively than primary tumor growth. Breast Cancer Res BCR. 2022;24:13.","journal-title":"Breast Cancer Res BCR"},{"key":"2346_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409260","volume":"12","author":"JA Ju","year":"2024","unstructured":"Ju JA, et al. Tubulin\u2010based microtentacles aid in heterotypic clustering of neutrophil\u2010differentiated HL\u201060 cells and breast tumor cells. Adv Sci. 2024;12:2409260.","journal-title":"Adv Sci"},{"key":"2346_CR34","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-07-6589","volume":"68","author":"RA Whipple","year":"2008","unstructured":"Whipple RA, et al. Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells. Cancer Res. 2008;68:5678\u201388.","journal-title":"Cancer Res"},{"key":"2346_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030884","volume":"15","author":"KT Chang","year":"2023","unstructured":"Chang KT, et al. Elevation of cytoplasmic calcium suppresses microtentacle formation and function in breast tumor cells. Cancers. 2023;15:884.","journal-title":"Cancers"},{"key":"2346_CR36","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1038\/onc.2010.360","volume":"29","author":"EM Balzer","year":"2010","unstructured":"Balzer EM, et al. c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene. 2010;29:6402\u20138.","journal-title":"Oncogene"},{"key":"2346_CR37","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.18632\/oncotarget.3360","volume":"6","author":"L Bhandary","year":"2015","unstructured":"Bhandary L, et al. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells. Oncotarget. 2015;6:6251\u201366.","journal-title":"Oncotarget"},{"key":"2346_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1158\/0008-5472.CAN-13-3563","volume":"75","author":"AE Boggs","year":"2015","unstructured":"Boggs AE, et al. \u03b1-tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion and invasive migration. Cancer Res. 2015;75:203\u201315.","journal-title":"Cancer Res"},{"key":"2346_CR39","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1038\/onc.2010.68","volume":"29","author":"MA Matrone","year":"2010","unstructured":"Matrone MA, et al. Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene. 2010;29:3217\u201327.","journal-title":"Oncogene"},{"key":"2346_CR40","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-09-4613","volume":"70","author":"RA Whipple","year":"2010","unstructured":"Whipple RA, et al. Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement. Cancer Res. 2010;70:8127\u201337.","journal-title":"Cancer Res"},{"key":"2346_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.yexcr.2017.05.024","volume":"357","author":"AN Killilea","year":"2017","unstructured":"Killilea AN, et al. Cytoskeletal organization in microtentacles. Exp Cell Res. 2017;357:291\u20138.","journal-title":"Exp Cell Res"},{"key":"2346_CR42","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","volume":"7","author":"E Schuster","year":"2021","unstructured":"Schuster E, et al. Better together: circulating tumor cell clustering in metastatic cancer. Trends Cancer. 2021;7:1020\u201332.","journal-title":"Trends Cancer"},{"key":"2346_CR43","doi-asserted-by":"publisher","first-page":"8275","DOI":"10.1158\/0008-5472.CAN-09-1067","volume":"69","author":"MI Vitolo","year":"2009","unstructured":"Vitolo MI, et al. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res. 2009;69:8275\u201383.","journal-title":"Cancer Res"},{"key":"2346_CR44","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1039\/D0LC00207K","volume":"20","author":"JA Ju","year":"2020","unstructured":"Ju JA, et al. Partial thermal imidization of polyelectrolyte multilayer cell tethering surfaces (TetherChip) enables efficient cell capture and microtentacle fixation for circulating tumor cell analysis. Lab Chip. 2020;20:2872\u201388.","journal-title":"Lab Chip"},{"key":"2346_CR45","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1111\/bph.70215","volume":"182","author":"M Posta","year":"2025","unstructured":"Posta M, Gy\u0151rffy B. Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets. Br J Pharmacol. 2025;182:5734\u201347.","journal-title":"Br J Pharmacol"},{"key":"2346_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2016.11.004","volume":"386","author":"Y-K Liang","year":"2017","unstructured":"Liang Y-K, et al. MCAM\/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial\u2013mesenchymal transition, decreased ER\u03b1 expression and AKT activation. Cancer Lett. 2017;386:65\u201376.","journal-title":"Cancer Lett"},{"key":"2346_CR47","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. S100A8\/A9-MCAM signaling promotes gastric cancer cell progression via ERK-c-Jun activation. Vitro Cell. Dev. Biol. Anim. (2025)","DOI":"10.1007\/s11626-025-01105-3"},{"key":"2346_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020974","volume":"23","author":"A Sharma","year":"2022","unstructured":"Sharma A, et al. Soluble CD146 as a potential target for preventing triple negative breast cancer MDA-MB-231 cell growth and dissemination. Int J Mol Sci. 2022;23:974.","journal-title":"Int J Mol Sci"},{"key":"2346_CR49","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/9\/1\/016001","volume":"9","author":"EH Cho","year":"2012","unstructured":"Cho EH, et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol. 2012;9:016001.","journal-title":"Phys Biol"},{"key":"2346_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10050134","author":"IE de Kruijff","year":"2018","unstructured":"de Kruijff IE, et al. The prevalence of CD146 expression in breast cancer subtypes and its relation to outcome. Cancers. 2018. https:\/\/doi.org\/10.3390\/cancers10050134.","journal-title":"Cancers"},{"key":"2346_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212416","volume":"22","author":"MC Rapanotti","year":"2021","unstructured":"Rapanotti MC, et al. MCAM\/MUC18\/CD146 as a multifaceted warning marker of melanoma progression in liquid biopsy. Int J Mol Sci. 2021;22:12416.","journal-title":"Int J Mol Sci"},{"key":"2346_CR52","doi-asserted-by":"publisher","first-page":"R596","DOI":"10.1016\/S0960-9822(02)01102-8","volume":"12","author":"EJ Clarke","year":"2002","unstructured":"Clarke EJ, Allan V. Intermediate filaments: vimentin moves in. Curr Biol. 2002;12:R596\u20138.","journal-title":"Curr Biol"},{"key":"2346_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.cels.2016.08.007","volume":"3","author":"Z Gan","year":"2016","unstructured":"Gan Z, et al. Vimentin intermediate filaments template microtubule networks to enhance persistence in cell polarity and directed migration. Cell Syst. 2016;3:252-263.e8.","journal-title":"Cell Syst"},{"key":"2346_CR54","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.18632\/oncotarget.2338","volume":"5","author":"NA Perry","year":"2014","unstructured":"Perry NA, Vitolo MI, Martin SS, Kontrogianni-Konstantopoulos A. Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells. Oncotarget. 2014;5:8558\u201368.","journal-title":"Oncotarget"},{"key":"2346_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030800","volume":"14","author":"JC Reader","year":"2022","unstructured":"Reader JC, et al. Microtentacle formation in ovarian carcinoma. Cancers. 2022;14:800.","journal-title":"Cancers"},{"key":"2346_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000147848","volume":"156","author":"C Birchmeier","year":"1996","unstructured":"Birchmeier C, Birchmeier W, Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel). 1996;156:217\u201326.","journal-title":"Acta Anat (Basel)"},{"key":"2346_CR57","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1074\/jbc.M007065200","volume":"276","author":"F Anfosso","year":"2001","unstructured":"Anfosso F, et al. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells *. J Biol Chem. 2001;276:1564\u20139.","journal-title":"J Biol Chem"},{"key":"2346_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.944487","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen Q, et al. A narrative review of circulating tumor cells clusters: a key morphology of cancer cells in circulation promote hematogenous metastasis. Front Oncol. 2022;12:944487.","journal-title":"Front Oncol"},{"key":"2346_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/340296","volume":"2012","author":"C Wai Wong","year":"2012","unstructured":"Wai Wong C, Dye DE, Coombe DR. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol. 2012;2012:340296.","journal-title":"Int J Cell Biol"},{"key":"2346_CR60","first-page":"5106","volume":"62","author":"L Mills","year":"2002","unstructured":"Mills L, et al. Fully human antibodies to MCAM\/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res. 2002;62:5106\u201314.","journal-title":"Cancer Res"},{"key":"2346_CR61","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<769::AID-IJC26>3.0.CO;2-#","volume":"73","author":"JP Johnson","year":"1997","unstructured":"Johnson JP, Bar-Eli M, Jansen B, Markhof E. Melanoma progression-associated glycoprotein MUC18\/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand. Int J Cancer. 1997;73:769\u201374.","journal-title":"Int J Cancer"},{"key":"2346_CR62","doi-asserted-by":"publisher","first-page":"11432","DOI":"10.1073\/pnas.1914294117","volume":"117","author":"KJ Wolf","year":"2020","unstructured":"Wolf KJ, et al. A mode of cell adhesion and migration facilitated by CD44-dependent microtentacles. Proc Natl Acad Sci U S A. 2020;117:11432\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2346_CR63","doi-asserted-by":"publisher","first-page":"C743","DOI":"10.1152\/ajpcell.00250.2007","volume":"294","author":"S Liang","year":"2008","unstructured":"Liang S, et al. Two-dimensional kinetics of \u03b22-integrin and ICAM-1 bindings between neutrophils and melanoma cells in a shear flow. Am J Physiol Cell Physiol. 2008;294:C743\u201353.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2346_CR64","doi-asserted-by":"publisher","first-page":"28845","DOI":"10.1074\/jbc.M109.042150","volume":"284","author":"VO Melnikova","year":"2009","unstructured":"Melnikova VO, et al. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM\/MUC18) expression and melanoma metastasis. J Biol Chem. 2009;284:28845\u201355.","journal-title":"J Biol Chem"},{"key":"2346_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.matbio.2014.06.002","volume":"38","author":"T Ishikawa","year":"2014","unstructured":"Ishikawa T, et al. Laminins 411 and 421 differentially promote tumor cell migration via \u03b16\u03b21 integrin and MCAM (CD146). Matrix Biol. 2014;38:69\u201383.","journal-title":"Matrix Biol"},{"key":"2346_CR66","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1074\/jbc.M117.783431","volume":"292","author":"F Colomb","year":"2017","unstructured":"Colomb F, et al. Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells. J Biol Chem. 2017;292:8381\u20139.","journal-title":"J Biol Chem"},{"key":"2346_CR67","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1182\/blood-2012-01-406108","volume":"120","author":"T Jiang","year":"2012","unstructured":"Jiang T, et al. CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis. Blood. 2012;120:2330\u20139.","journal-title":"Blood"},{"key":"2346_CR68","unstructured":"Pfizer. Randomized, double-blind phase 2 study of Axitinib (Ag-013736) with or without dose titration in patients with metastatic renal cell carcinoma. https:\/\/clinicaltrials.gov\/study\/NCT00835978 (2017)."},{"key":"2346_CR69","unstructured":"Assistance Publique Hopitaux De Marseille. Precision immuno-oncology for advanced non-small cell lung cancer patients with PD-1 ICI resistance (PIONeeR-BioMarkers (BM) Profiling). https:\/\/clinicaltrials.gov\/study\/NCT03493581 (2023)."},{"key":"2346_CR70","unstructured":"Assistance Publique Hopitaux De Marseille. Predictive value of soluble CD146 in patients with recurrent glioblastoma treated by Bevacizumab. https:\/\/clinicaltrials.gov\/study\/NCT06001281 (2024)."},{"key":"2346_CR71","unstructured":"National Cancer Institute (NCI). A Phase I&#x2F;II Trial of BAY 43-9006 (Sorafenib) in Combination With Anastrozole in Patients With Metastatic Breast Cancer. https:\/\/clinicaltrials.gov\/study\/NCT00217399 (2014)."},{"key":"2346_CR72","doi-asserted-by":"publisher","first-page":"112283","DOI":"10.18632\/oncotarget.22736","volume":"8","author":"M Nollet","year":"2017","unstructured":"Nollet M, et al. A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule. Oncotarget. 2017;8:112283\u201396.","journal-title":"Oncotarget"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02346-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:03:02Z","timestamp":1791896582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02346-0","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Maryland School of Medicine owns patents on the subject of microtentacles and microfluidic cell tethering that list one of the authors on the current manuscript (Stuart S. Martin) as an inventor.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"174"}}